newsfilter
← Latest News
GlobeNewswire·

Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results

Reported $456.3 million in cash resources as of December 31, 2023, which when combined with certain anticipated regulatory milestone payments provides projected cash runway into 2H 2027Initiation of rolling biologics